Cargando…
Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease
Autores principales: | Sciascia, Savino, Parodis, Ioannis, Karim, Mohammed Yousuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298074/ https://www.ncbi.nlm.nih.gov/pubmed/35874715 http://dx.doi.org/10.3389/fimmu.2022.962088 |
Ejemplares similares
-
Editorial: Next generation B cell targeting therapies in autoimmune diseases
por: Li, Rui, et al.
Publicado: (2023) -
B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab
por: Parodis, Ioannis, et al.
Publicado: (2022) -
Editorial: Autoimmune Diabetes: Molecular Mechanisms and Neoantigens
por: Kent, Sally C., et al.
Publicado: (2022) -
Editorial: Immune Monitoring Responses in Renal Autoimmune Diseases
por: Teng, Y. K. Onno, et al.
Publicado: (2021) -
Editorial: Autoimmune Vasculitis - Advances in Pathogenesis and Therapies
por: Ooi, Joshua D., et al.
Publicado: (2021)